Anna-Maria Wiesinger

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Palliative Care

Patient Reported Outcomes

Ejection Fraction

End Stage Renal Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna-Maria Wiesinger, Hannah Strobl, Florian B Lagler
Individual Treatment Trials-Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Anna-Maria Wiesinger, Hannah Strobl, Florian B Lagler
Individual Treatment Trials-Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Anna-Maria Wiesinger, Brian W Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B Lagler
RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15 , 1565. Pharmaceutics 15 (11) (2023)
Anna-Maria Wiesinger, Brian W Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B Lagler
An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 15 (5) (2023)
Anna-Maria Wiesinger, Hannah Strobl, Florian B Lagler
Individual Treatment Trials-Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)